首页> 外国专利> PEPTIDE THAT ELICITS NEUTRALIZING ANTIBODIES TARGETING THE HIV CO-RECEPTOR, CCR5

PEPTIDE THAT ELICITS NEUTRALIZING ANTIBODIES TARGETING THE HIV CO-RECEPTOR, CCR5

机译:使中和抗体靶向HIV共同受体CCR5的肽

摘要

The present invention relates, e.g., to an isolated peptide comprising a sequence of contiguous amino acids that is at least about 60% identical (e.g., at least about 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98% or 100% identical) to the sequence E-W-Q-K-E-G-L-V-T-L-W-L (SEQ ID NO:1), or an active variant of an isolated peptide comprising SEQ ID NO:1. Neutralizing antibodies generated by, or specific for, such peptides are also described, in particular antibodies which are specific for the HIV co-receptor, CCR5, and which inhibit infection of a host cell by HIV. Neutralizing single strand and complete human monoclonal antibodies against CCR5 are described. Methods of using such peptides or antibodies, for inhibiting infection by HIV, are also described.
机译:本发明例如涉及分离的肽,其包含至少约60%相同(例如,至少约60%,65%,70%,75%,80%,85%,与序列EWQKEGLVTLWL(SEQ ID NO:1)或包含SEQ ID NO:1的分离肽的活性变体具有90%,95%,98%或100%的同一性)。还描述了由这种肽产生的或对这种肽具有特异性的中和抗体,特别是对HIV共受体CCR5具有特异性并且抑制宿主细胞被HIV感染的抗体。描述了中和抗CCR5的单链和完整人类单克隆抗体。还描述了使用这种肽或抗体抑制HIV感染的方法。

著录项

  • 公开/公告号US2010266598A1

    专利类型

  • 公开/公告日2010-10-21

    原文格式PDF

  • 申请/专利权人 HANA GOLDING;SURENDER KHURANA;

    申请/专利号US20090647789

  • 发明设计人 HANA GOLDING;SURENDER KHURANA;

    申请日2009-12-28

  • 分类号A61K39/395;A61K39;A61K38/10;C07K7/08;C07K16;C07H21/04;A61P31/18;C12N15/63;C12N5/10;G01N33/53;

  • 国家 US

  • 入库时间 2022-08-21 18:56:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号